Delaware Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• Micro- and Nanoplastics Associated With Structural Plaque Vulnerability in ACS
  Circulating levels of micro- and nanoplastics (MNPs) were associated with structural plaque vulnerability in acute coronary syndrome (ACS), using optical coherence tomography (OCT), according to research published May 20 in JACC: Cardiovascular Imaging.
• ALLEVIATE-HF: ICM-Based HF Risk Detection and CV Outcomes; Arrythmia Burden
  Heart failure (HF) risk detection with an insertable cardiac monitor (ICM) paired with a centrally coordinated nurse-led diuretic intervention was safe but did not reduce cardiovascular events in ambulatory patients with recent symptomatic HF events, according to findings from the ALLEVIATE-HF trial published May 27 in JACC.
• MAUDE Registry: Late Pericardial Effusions Post LAAO Device Implantation
  Late pericardial effusion (LPE) following left atrial appendage occlusion (LAAO) device implantation was associated with negative patient outcomes, including mortality, suggesting the need for long-term surveillance of these patients, according to an analysis of the Manufacturer and User Facility Device Experience (MAUDE) Registry...
• From the ACC President: Key Takeaways From ACC’s May BOT Meeting
  ACC’s Board of Trustees (BOT) meetings are essential to providing strategic guidance to our committees and work groups as they advance and implement priorities across education, science, membership, our registries and more. The recent May meeting was especially meaningful as my first official meeting as ACC President – and the Board was thrilled to welcome […]
• The Evolut Low Risk Trial: Six-Year Outcomes of TAVR vs. SAVR in Patients at Low Surgical Risk
  The Evolut Low Risk trial was a prospective randomized trial that enrolled patients at low surgical risk with severe trileaflet aortic stenosis from 87 international sites between 2016 and 2019.